- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Bullion Gold Discoveries Corp.: Bullion Gold Returns 22.2 g/t Au + 24.5 g/t Ag over 1 metre in Channel R21 at Terragold | 411 | Newsfile | Montreal, Quebec--(Newsfile Corp. - September 9, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the final results of its channel sampling program... ► Artikel lesen | |
| 25.08. | Bullion Gold Discoveries Corp: Bullion Gold completes Terragold validation drilling | 1 | Stockwatch | ||
| BULLION GOLD DISCOVERIES Aktie jetzt für 0€ handeln | |||||
| 25.08. | Bullion Gold Discoveries Corp.: Bullion Gold Completes Terragold Validation Program with 3,909 Metres Drilled | 318 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 25, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the completion of its validation drilling program... ► Artikel lesen | |
| 09.07. | Bullion Gold Discoveries Corp: Bullion Gold private placement | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp: Bullion Gold samples 5.4 g/t Au at Terragold project | 1 | Stockwatch | ||
| 30.06. | Bullion Gold Discoveries Corp.: Bullion Reports 5.4 g/t Au and 5.0 g/t Ag in Surface Grab Sample and Commences Validation Drilling at Terragold | 426 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 30, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to provide an exploration update from Bullion's flagship and... ► Artikel lesen | |
| 23.06. | Bullion Gold Discoveries Corp: Bullion shareholders approve all matters at AGM | 1 | Stockwatch | ||
| 23.06. | Bullion Gold Discoveries Corp.: Bullion Announces Results of Annual General Meeting | 796 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 22, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the voting results from its Annual General Meeting... ► Artikel lesen | |
| 18.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 18.06.2026 | 467 | Xetra Newsboard | The following instruments on XETRA do have their first trading 18.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.06.2026
Aktien
1 SE0029278985 Tangen Industrikapital... ► Artikel lesen | |
| 17.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.06.2026 | 456 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 17.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.06.2026ISIN NameCA1202272029 BULLION... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp: Bullion Gold closes $2-million private placement | 1 | Stockwatch | ||
| 17.06. | XFRA ISIN CHANGE | 310 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA1202272029 Bullion Gold Discoveries Corp. 17.06.2026 CA1199331093 Bullion Gold Discoveries Corp. 18.06.2026 Tausch... ► Artikel lesen | |
| 17.06. | Bullion Gold Discoveries Corp.: Bullion Closes $2M Private Placement | 453 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it has closed its previously announced non-brokered... ► Artikel lesen | |
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 461 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 16.06. | XFRA B4R: AUSSETZUNG/SUSPENSION | 198 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBULLION GOLD RES... ► Artikel lesen | |
| 13.06. | Bullion Gold Resources Corp (2): Bullion Gold name change to Bullion Gold Discoveries | 6 | Stockwatch | ||
| 12.06. | Bullion Gold Resources Corp. kündigt Namensänderung an | 1 | GoldSeiten.de | ||
| 12.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources to change name | 1 | Stockwatch | ||
| 11.06. | Bullion Gold Resources Corp.: Bullion Announces Name Change to Bullion Gold Discoveries Corp | 608 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 11, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that it will complete a name change from "Bullion... ► Artikel lesen | |
| 09.06. | Bullion Gold Resources Corp (2): Bullion Gold moves field crew to Terragold | 1 | Stockwatch |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KYMERA THERAPEUTICS | 115,43 | 0,00 % | Can KT-621 Mark a Turning Point for Kymera Therapeutics? | ||
| TARSUS PHARMACEUTICALS | 82,77 | 0,00 % | Tarsus Pharmaceuticals, Inc: Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care | Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt's disease, a potentially blinding disease with no FDA-approved... ► Artikel lesen | |
| RELAY THERAPEUTICS | 18,670 | 0,00 % | Relay Therapeutics: Zovegalisib-Pipeline steht vor entscheidenden Meilensteinen | ||
| EDGEWISE THERAPEUTICS | 43,390 | 0,00 % | Edgewise Therapeutics Reports Second Quarter 2026 Financial Results | - Announced positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) -
- ... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 41,620 | 0,00 % | Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress | ||
| KINIKSA PHARMACEUTICALS | 78,52 | 0,00 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution | - ARCALYST (rilonacept) Q2 2026 net product revenue of $243.6 million, representing ~55% year-over-year growth -- ARCALYST 2026 expected net product revenue increased to $980 - $995 million -- KPL-387... ► Artikel lesen | |
| TANGO THERAPEUTICS | 24,020 | 0,00 % | Tango Therapeutics, Inc.: Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 data Phase 1/2 data from combination... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 17,520 | -0,11 % | Mercks 30-Milliarden-Dollar-Blockbuster bekommt neue Konkurrenz - warum Big Pharma schon die nächste Plattform sucht | ||
| TYRA BIOSCIENCES | 22,030 | +0,09 % | Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib | TYRA's mission is to make dabogratinib the clear first-line treatment choice for patients with LG IR NMIBC
Favorable safety and tolerability results support chronic... ► Artikel lesen | |
| ADMA BIOLOGICS | 9,450 | 0,00 % | Kehoe Law Firm, P.C.: ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches | Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. ("ADMA," "ADMA Biologics," or... ► Artikel lesen | |
| MINERALYS THERAPEUTICS | 30,500 | 0,00 % | Mineralys auf Wells Fargo Konferenz: Markteinführung von Lorundrostat nimmt Gestalt an | ||
| DYNE THERAPEUTICS | 19,190 | 0,00 % | Aktien New York Ausblick: Dow schwächelt weiter - Nasdaq stabil erwartet | NEW YORK (dpa-AFX) - Die US-Börsen steuern nach dem verlängerten Wochenende am Dienstag auf eine durchwachsene Eröffnung zu. Auf die Stimmung drückten die weiter steigenden Ölpreise, die der Angst... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 23,830 | -0,04 % | Arcutis Biotherapeutics, Inc.: Arcutis Expands Board of Directors with Appointment of Chris Peetz | WESTLAKE VILLAGE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in... ► Artikel lesen | |
| INHIBRX BIOSCIENCES | 112,32 | -0,48 % | Inhibrx Biosciences, Inc.: Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study |
First OX40 agonist to demonstrate clinical benefit in a randomized study
INBRX-106 plus pembrolizumab delivers a 48.3% cORR and 72.4% of patients remain progression... ► Artikel lesen | |
| COGENT BIOSCIENCES | 34,150 | 0,00 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) | Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated... ► Artikel lesen |
BULLION GOLD DISCOVERIES CORPORATION gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,046 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD DISCOVERIES CORPORATION finden Sie auf Wallstreet Online.